SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-24-000179
Filing Date
2024-04-19
Accepted
2024-04-19 17:15:48
Documents
13
Period of Report
2024-04-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20240418_8k.htm   iXBRL 8-K 27302
  Complete submission text file 0001520138-24-000179.txt   199871

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bivi-20240418.xsd EX-101.SCH 3027
3 XBRL LABEL FILE bivi-20240418_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bivi-20240418_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240418_8k_htm.xml XML 3504
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 24858895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)